Cancer genetics
Carlo Croce: Ohio State investigation and related lawsuits, 2017 to 2026
Ohio State University College of Medicine
Cleared Ohio State found no research misconduct in 2021 but removed him from an endowed chair, and the Court of Claims of Ohio ruled for the university on his remaining claims in July 2026.1
Papers
| Paper | Action | Date | Reason stated |
|---|---|---|---|
| Nine retracted papers, three expressions of concern and 17 corrections recorded by the Retraction Watch Database as of July 2019 Multiple journals, https://retractionwatch.com/2019/07/19/osu-cancer-researcher-carlo-croce-loses-appeal-of-new-york-times-libel-suit/2 | Retracted | to 2019-07 | Counts as reported by Retraction Watch from its database. Individual notices not read. |
Investigations
- Ohio State University College of Medicine Investigation Committee, July 2021Determined the allegations did not amount to research misconduct, but identified problems with some publications and concerns about his laboratory management, and recommended revoking his endowed chair, as described by the Court of Claims of Ohio.1
- US Court of Appeals for the Sixth Circuit, July 2019Affirmed the dismissal of most of his libel claims against The New York Times over a 2017 article, according to Retraction Watch.2
- Court of Claims of Ohio (Judge Lisa L. Sadler, cases 2020-00626JD and 2022-00187JD), 22 July 2026Granted Ohio State summary judgment on all remaining claims, including over his removal as endowed chair and the university's duty to restore his reputation.1
Response
His attorney declined to answer Retraction Watch's questions in 2019. His lawsuits allege the investigation was conflicted and failed to restore his reputation, as summarised by the court.1,2
Sources
- Court of Claims of Ohio (Supreme Court of Ohio Reporter of Decisions), Croce v. Ohio State University Board of Trustees, 2026-Ohio-3201 (22 July 2026)
- Retraction Watch, OSU cancer researcher Carlo Croce loses appeal of New York Times libel suit (19 July 2019)